| Dr Yesha Mukesh Thakkar, DO | |
|
20 Herrell Rd, Villa Rica, GA 30180-5527 | |
| (630) 873-9445 | |
| Not Available |
| Full Name | Dr Yesha Mukesh Thakkar |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 7 Years |
| Location | 20 Herrell Rd, Villa Rica, Georgia |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275066565 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tmc-behavioral Health Of West Georgia | 2163714635 | 26 |
News Archive
Accelrys, Inc., a leading scientific enterprise R&D software and services company, today announced the Accelrys Modeling and Simulation Suite, a pillar of the new Accelrys Enterprise R&D Architecture.
GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK's Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.
PVA TePla America, Inc., a subsidiary of PVA TePla AG announced today it has formed a global strategic alliance with Integrated Surface Technologies MENLO PARK, CA. The alliance will leverage the global sales, contract services, field service and development resources of PTA and IST's silane surface chemistry technologies as well as atomic layer deposition techniques.
The U.S. Food and Drug Administration today approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the treatment of adult patients with relapsed or refractory mycosis fungoides or Sézary syndrome after at least one prior systemic therapy.
› Verified 6 days ago
| Entity Name | Tmc-behavioral Health Of West Georgia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356795462 PECOS PAC ID: 2163714635 Enrollment ID: O20160705000347 |
News Archive
Accelrys, Inc., a leading scientific enterprise R&D software and services company, today announced the Accelrys Modeling and Simulation Suite, a pillar of the new Accelrys Enterprise R&D Architecture.
GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK's Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.
PVA TePla America, Inc., a subsidiary of PVA TePla AG announced today it has formed a global strategic alliance with Integrated Surface Technologies MENLO PARK, CA. The alliance will leverage the global sales, contract services, field service and development resources of PTA and IST's silane surface chemistry technologies as well as atomic layer deposition techniques.
The U.S. Food and Drug Administration today approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the treatment of adult patients with relapsed or refractory mycosis fungoides or Sézary syndrome after at least one prior systemic therapy.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yesha Mukesh Thakkar, DO 20 Herrell Rd, Villa Rica, GA 30180-5527 Ph: (630) 873-9445 | Dr Yesha Mukesh Thakkar, DO 20 Herrell Rd, Villa Rica, GA 30180-5527 Ph: (630) 873-9445 |
News Archive
Accelrys, Inc., a leading scientific enterprise R&D software and services company, today announced the Accelrys Modeling and Simulation Suite, a pillar of the new Accelrys Enterprise R&D Architecture.
GlaxoSmithKline (GSK) and Aptuit, Inc. announced today that they have finalized an agreement for Aptuit to acquire operations at GSK's Medicines Research Centre in Verona, Italy. The arrangement, which is effective as of July 1, 2010, provides for ongoing employment of the staff at the centre and for Aptuit to supply GSK with R&D services from the facilities. Financial terms have not been disclosed.
PVA TePla America, Inc., a subsidiary of PVA TePla AG announced today it has formed a global strategic alliance with Integrated Surface Technologies MENLO PARK, CA. The alliance will leverage the global sales, contract services, field service and development resources of PTA and IST's silane surface chemistry technologies as well as atomic layer deposition techniques.
The U.S. Food and Drug Administration today approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the treatment of adult patients with relapsed or refractory mycosis fungoides or Sézary syndrome after at least one prior systemic therapy.
› Verified 6 days ago